Patents Assigned to FROST BIOLOGIC, INC.
  • Antimitotic amides for the treatment of cancer and proliferative disorders
    Patent number: 12383533
    Abstract: Novel, antimitotic heteroaryl amides and pharmaceutically acceptable salts of Formula I where Ar, R5, R6, R8, R9, R11, X1, and X2 are as defined herein, as compounds for treatment and prevention of cancer and proliferative diseases and disorders.
    Type: Grant
    Filed: September 13, 2021
    Date of Patent: August 12, 2025
    Assignee: FROST BIOLOGIC, INC.
    Inventor: Adam Siddiqui-Jain
  • Antimitotic amides for the treatment of cancer and proliferative disorders
    Patent number: 11129813
    Abstract: Novel, antimitotic heteroaryl amides and pharmaceutically acceptable salts of Formula I where Ar, R5, R6, R8, R9, R11, X1, and X2 are as defined herein, as compounds for treatment and prevention of cancer and proliferative diseases and disorders.
    Type: Grant
    Filed: September 3, 2020
    Date of Patent: September 28, 2021
    Assignee: Frost Biologic, Inc.
    Inventor: Adam Siddiqui-Jain
  • Antimitotic amides for the treatment of cancer and proliferative disorders
    Patent number: 10772872
    Abstract: Novel, antimitotic heteroaryl amides and pharmaceutically acceptable salts of Formula I where Ar, R5, R6, R8, R9, R11, X1, and X2 are as defined herein, as compounds for treatment and prevention of cancer and proliferative diseases and disorders.
    Type: Grant
    Filed: June 29, 2018
    Date of Patent: September 15, 2020
    Assignee: Frost Biologic, Inc.
    Inventor: Adam Siddiqui-Jain
  • ANTIMITOTIC AMIDES FOR THE TREATMENT OF CANCER AND PROLIFERATIVE DISORDERS
    Publication number: 20180325871
    Abstract: Novel, antimitotic heteroaryl amides and pharmaceutically acceptable salts of Formula I where Ar, R5, R6, R8, R9, R11, X1, and X2 are as defined herein, as compounds for treatment and prevention of cancer and proliferative diseases and disorders.
    Type: Application
    Filed: June 29, 2018
    Publication date: November 15, 2018
    Applicant: FROST BIOLOGIC, INC.
    Inventor: Adam Siddiqui-Jain
  • Antimitotic amides for the treatment of cancer and proliferative disorders
    Patent number: 10016398
    Abstract: Novel, antimitotic heteroaryl amides and pharmaceutically acceptable salts of Formula I where Ar, R5, R6, R8, R9, R11, X1, and X2 are as defined herein, as compounds for treatment and prevention of cancer and proliferative diseases and disorders.
    Type: Grant
    Filed: February 20, 2015
    Date of Patent: July 10, 2018
    Assignee: Frost Biologic, Inc.
    Inventor: Adam Siddiqui-Jain
  • ANTIMITOTIC AMIDES FOR THE TREATMENT OF CANCER AND PROLIFERATIVE DISORDERS
    Publication number: 20170172984
    Abstract: Novel, antimitotic heteroaryl amides and pharmaceutically acceptable salts of Formula I where Ar, R5, R6, R8, R9, R11, X1, and X2 are as defined herein, as compounds for treatment and prevention of cancer and proliferative diseases and disorders.
    Type: Application
    Filed: February 20, 2015
    Publication date: June 22, 2017
    Applicant: FROST BIOLOGIC, INC.
    Inventor: Adam SIDDIQUI-JAIN